Kohima News Paper

Graves’ disease Market Insights and Market Forecast by DelveInsight

 Breaking News
  • No posts were found

Graves’ disease Market Insights and Market Forecast by DelveInsight

June 15
19:20 2021
Graves’ disease Market Insights and Market Forecast by DelveInsight


Graves’ disease Market” has been added to DelveInsight


Graves’ disease Overview

Graves’ disease (GD) is an autoimmune disorder that causes the overproduction of thyroid hormones and consequent cascade of systemic metabolism dysfunction. It may also affect other multiple organs including eyes and skin. It is the most common cause of hyperthyroidism. It results from the stimulation of autoantibodies to the thyrotropin receptor of thyroid follicular cells. It usually occurs between 30 and 50 years of age, but all ages can be affected.


Graves’ disease Market: Forecast

DelveInsight’s “Graves’ Disease – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Graves’ Disease, historical and forecasted epidemiology as well as the Graves’ Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Graves’ disease Market: Report

The Graves’ Disease market report provides current treatment practices, emerging drugs, Graves’ Disease market share of the individual therapies, current and forecasted Graves’ Disease market Size from 2018 to 2030 segmented by seven major markets. The Report also covers current Graves’ Disease treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.


Request Free Sample Copy- https://www.delveinsight.com/sample-request/graves-disease-market


Graves’ disease Market: Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Graves’ disease Market: Symptoms

Some of the common symptoms are: weight loss, anxiety, restlessness, tremors, irritability, insomnia, heat intolerance, sweating, chest pain, palpitations, shortness of breath, difficulty breathing, increased stool frequency (with or without diarrhea),irregular menstrual periods, muscle weakness etc. Like all autoimmune diseases, it occurs more commonly in patients with a positive family history.


Graves’ disease Market: Disease

The disease is more common in monozygotic twins than in dizygotic twins. It is precipitated by environmental factors like stress, smoking, infection, iodine exposure, and postpartum, as well as after highly active antiretroviral therapy (HAART) due to immune reconstitution. Graves’ Disease is more common in women as compared to men.


Graves’ disease Market: Size

 The market size of Graves’ Disease in seven major markets is approximately USD 301.00 million in 2017. United States is expected to grab the highest market share of Graves’ disease market with ~USD 147.9 million in 2017. Among EU5 countries, Germany has the highest market size, with ~USD 26.8 million, while Spain had the lowest market size of Graves’ disease, with ~USD 13.0 million in 2017.


Graves’ disease Market: Emerging Drugs Analysis

From the last five to six decades, the market of Graves’ disease is based on Antithyroid drugs, Radioactive Iodine, and Surgery. Therefore, until now, the market hasshown slow growth. Hitherto, the market consists of various unmet needs which include the necessity of drugs to cure the disease with fewer side effects, and the need for thyroid hormone replacement medication. With continuous efforts in research and development, recently, few companies such as Horizon Pharma, Novartis, Apitope, and Immunovant are developing therapeutic molecules for the treatment of patients with Grave’s Disease and its manifestations GO (Gravis ophthalmopathy).


Table of content

1. Key Insights

2. Executive Summary of Graves’ Disease

3. Competitive Intelligence Analysis for Graves’ Disease

4. Graves’ Disease: Market Overview at a Glance

5. Graves’ Disease: Disease Background and Overview

6. Patient Journey

7. Graves’ Disease Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Graves’ Disease Treatment

11. Marketed Products

12. Emerging Therapies

13. Graves’ Disease: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Graves ‘disease

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight


Graves ‘disease Market: Report Highlights

  • In the coming years, Graves’ Disease market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Graves’ Disease R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition       
  • Major players are involved in developing therapies for Graves’ Disease. Launch of emerging therapies will significantly impact the Graves’ Disease market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Graves’ Disease
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities


Why should you buy this report?

  • The report will help in developing business strategies by understanding trends shaping and driving the Graves’ Disease market
  • To understand the future market competition in the Graves’ Disease market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Graves’ Disease in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Graves’ Disease market
  • To understand the future market competition in the Graves’ Disease market.


 About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/